France· FR:67365141
EVISTA 60 mg, comprimé pelliculé
A raloxifene product containing chlorhydrate de raloxifène, registered in France by SUBSTIPHARM, on the national reimbursement list. The same ATC class is registered in 19 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Raloxifene is registered in 19 of 19 countries.
Countries holding a registration under ATC G03XC01 (raloxifene), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 11 of them publish a price we can compare per daily dose
Raloxifene · ATC G03XC01
19 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of raloxifene costs, country by country.
Normalised to the WHO defined daily dose (60 mg), the median price runs from $0.44 in France to $1.28 in Switzerland — a ×2.9 gap.
- France: $0.44 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Raloxifene · price per daily dose (60 mg)
USD · FX 28 Sept 2026
- CH Switzerland$1.28
- ES Spain$0.84
- IT Italy$0.70
- FR France$0.44
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- CHLORHYDRATE DE RALOXIFÈNE
- Manufacturer
- SUBSTIPHARM
- Country
- France (FR)
- ATC code
- G03XC01
- ATC class
- Raloxifene
- Defined daily dose
- 60 mg, O
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 7
7 priced- cip133400934827266plaquette(s) thermoformée(s) PVC polyéthylène (ACLAR RX) polytrifluorochloroéthylène de 28 comprimé(s)EUR 12.03
- cip133400934827327plaquette(s) thermoformée(s) PVC polyéthylène (ACLAR RX) polytrifluorochloroéthylène de 84 comprimé(s)EUR 34.08
- cip133400949503650plaquette(s) thermoformée(s) PVC polyéthylène (ACLAR RX) polytrifluorochloroéthylène de 28 comprimé(s) (distributeur parallèle : Laboratoire Mediwin Ldt)EUR 11.43
- cip133400949503711plaquette(s) thermoformée(s) PVC polyéthylène (ACLAR RX) polytrifluorochloroéthylène de 84 comprimé(s) (distributeur parallèle : Laboratoire Mediwin Ldt)EUR 32.4
- cip133400949508273plaquette(s) thermoformée(s) PVC polyéthylène (ACLAR RX) polytrifluorochloroéthylène de 28 comprimé(s) (distributeur parallèle : PHARMA LAB)EUR 11.43
- cip133400949508334plaquette(s) thermoformée(s) PVC polyéthylène (ACLAR RX) polytrifluorochloroéthylène de 84 comprimé(s) (distributeur parallèle : PHARMA LAB)EUR 32.4
- cip133400949510115plaquette(s) thermoformée(s) PVC polyéthylène (ACLAR RX) polytrifluorochloroéthylène de 84 comprimé(s) (distributeur parallèle : Inter Trade Pharma)EUR 38.78
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
183 interactions on record for raloxifene.
Graded by severity as the source publishes them — 8 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Raloxifene · interactions on record
183 records
- 8 severe
- 12 moderate
- 6 minor
- 157 info
Most severe, free to view
- Tranexamic acidB02AA02severe
- BexaroteneL01XF03severe
- CarfilzomibL01XG02severe
- BexarotenL01XX25severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Raloxifene in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United Statesraloxifene hydrochlorideGlenmark Pharmaceuticals Inc., USA
- SpainEVISTA 60 MG COMPRIMIDOS RECUBIERTOS CON PELICULASubstipharm
- CzechiaEVISTASubstipharm, Paris
- IrelandEvista 60 mg film coated tabletsSubstipharm
- SwedenEvista 60 mg Filmdragerad tablettSubstipharm
- BelgiumOptruma 60 mgEli Lilly Nederland
- FinlandEvistaSubstipharm
- NetherlandsEvista 60 mg, omhulde tablettenSubstipharm
Authorised across Europe · EMA
The same active substance is authorised in 15 EEA countries. Names it is sold under:
- Austria · Raloxifen Stada
- Cyprus · Ostiral
- Germany · Raloxifen Al, Raloxifen-Hcl Hexal
- Spain · Raloxifeno Aurovitas, Raloxifeno Cinfamed
- United Kingdom (Northern Ireland) · Evirex, Ostiral
- Greece · Ostiral
- Hungary · Clastellos, Raloxibone
- Iceland · Evista, Optruma
- Italy · Raloxifene Sandoz
- Liechtenstein · Evista, Optruma
- Netherlands · Raloxifeenhydrochloride Brillpharma, Raloxifene Hydrochloride Aurobindo
- Norway · Evista, Optruma
- Portugal · Raloxifeno Ciclum, Raloxifeno Exeltis
- Romania · Raloxifen Arena
- Sweden · Raloxifen Stada
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/19e57679-4b65-4e35-94ea-30d108ce76d9 GET /v1/drugs/19e57679-4b65-4e35-94ea-30d108ce76d9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "67365141",
"date_amm": "1998-08-05",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/98/073",
"substance": "CHLORHYDRATE DE RALOXIFÈNE",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé pelliculé",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about raloxifene.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.